See What HealthDay Can Do For You
Contact Us

Less Morbidity Seen for High-Intensity Focused U/S of Fibroids

Ultrasound treatment of uterine fibroids appears to cause less morbidity than surgery


MONDAY, May 1, 2017 (HealthDay News) -- High-intensity focused ultrasound (HIFU) causes substantially less morbidity than surgery for treatment of uterine fibroids, with similar long-term quality of life (QoL), according to a study published online April 19 in BJOG.

Jinyun Chen, from Chongqing Medical University in China, and colleagues evaluated the clinical outcomes of HIFU and surgery in treating uterine fibroids among Chinese women with symptomatic fibroids participating in the multicenter IDEAL exploratory study. Of the 2,411 participants, 1,353 received HIFU, 472 hysterectomy and 586 myomectomy.

The researchers found that compared with surgery patients, HIFU patients were significantly younger, slimmer, better educated, and wealthier. After HIFU, both Uterine Fibroid Symptom score and QoL improved more rapidly than after surgery, although absolute differences were small. Major adverse events occurred in 0.2 percent of HIFU patients and in 12.6 percent of surgical cases.

"Despite group baseline differences and lack of blinding, these findings support the need for an RCT of HIFU treatment for fibroids," write the authors.

Several authors disclosed ties to Chongqing Haifu Medical Technology Inc., and one disclosed ties to NERCUM.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.